Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Urology

• Publication date

  2003-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0090-4295(03)00359-5PMID 12837435
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Re: Long-term efficacy of sildenafil and tachyphylaxis effect.

  2002cited by this paper
• Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses.

  2002cited by this paper
• After two years, did Viagra live up to its expectations?

  2001cited by this paper
• Physician-patient dialogue and clinical evaluation of erectile dysfunction.

  2001cited by this paper
• Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors.

  2001cited by this paper
• Long-term efficacy of sildenafil and tachyphylaxis effect.

  2001cited by this paper
• Patient and partner satisfaction with Viagra (sildenafil citrate) treatment as determined by the Erectile Dysfunction Inventory of Treatment Satisfaction Questionnaire.

  2001cited by this paper
• After two years, did Viagra live up to its expectations?

  2001cited by this paper
• Quality of life in patients with spinal cord injury receiving VIAGRA® (sildenafil citrate) for the treatment of erectile dysfunction

  2000cited by this paper
• The worldwide prevalence and epidemiology of erectile dysfunction

  2000cited by this paper
• Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction.

  2000cited by this paper
• Prospective pilot study of sildenafil for treatment of postradiotherapy erectile dysfunction in patients with prostate cancer.

  1999cited by this paper
• [Quality of life for patients].

  1999cited by this paper
• Sildenafil citrate (Viagra) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects.

  1999cited by this paper
• Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

  1999cited by this paper
• Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function.

  1999cited by this paper
• Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man.

  1999cited by this paper
• Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.

  1998cited by this paper
• Health outcomes variables important to patients in the treatment of erectile dysfunction.

  1998cited by this paper
• Reports at European Urology Congress reflect issues of interest to aging men.

  1998cited by this paper
• The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

  1997cited by this paper
• NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence.

  1993cited by this paper
• Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle.

  1990cited by this paper
• Impotence.

  1955cited by this paper

• Histopathological and real–time PCR analysis of alterations in the rat brain within the Glycerol–induced Crush Syndrome

  2026influential citation
• Evaluation of tadalafil in combination with Low-Intensity Pulsed Ultrasound (LIPUS) for erectile dysfunction: a protocol for a randomized controlled trial (SPIRIT Compliant)

  2025influential citation
• Penile cancer treatment and sexuality: a narrative review

  2025cites this paper
• Tadalafil for Treatment of Pulmonary Hypertension: Mechanisms, Evidence, and Emerging Perspectives.

  2025cites this paper
• Evolving medical management of erectile dysfunction: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024).

  2025cites this paper
• Combining tadalafil and hyperbaric oxygen therapy protects against ovarian ischemia-reperfusion damage in rats

  2025cites this paper
• Synergy between oral PDE5 inhibitors and topically applied nitric oxide microparticles on the erectile response in a rat model of cavernous nerve injury.

  2025cites this paper
• Erectile dysfunction in hypercholestermic patients

  2025cites this paper
• Comparative efficacy of on-demand Sildenafil, Tadalafil and daily Tadalafil for treatment of erectile dysfunction: A 12-week randomized controlled study

  2025cites this paper
• Cross-cultural Validation of the Arizona Sexual Experience Scale (ASEX) in 42 Countries and 26 Languages

  2024cites this paper
• Management of Persistent Erectile Dysfunction after COVID-19 Infection: An 18-Month Follow-Up Case Report

  2023cites this paper
• Erectile response profiles of men using PDE5 inhibitors combined with intracavernosal injections as part of a penile rehabilitation program after radical prostatectomy.

  2023cites this paper
• Nebivolol protects erectile functions compared to Metoprolol in hypertensive men with atherogenic, venogenic, psychogenic erectile dysfunction: A prospective, randomized, cross-over, clinical trial.

  2022cites this paper
• Application of hydrophilic polymers for the preparation of tadalafil solid dispersions: micromeritics properties, release and erectile dysfunction studies in male rats

  2022cites this paper
• Tadalafil against hyperoxia‐induced oxidative stress; an experimental study

  2022cites this paper
• Effect of Topical Tadalafil Gel in Imiquimod-induced Psoriasiform Skin Inflammation in Mice

  2021cites this paper
• Effect of low-dose tadalafil once daily on glycemic control in patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, placebo-controlled pilot study

  2021cites this paper
• Aphrodisiac agents used in traditional medicine and their mechanism of action - A Review

  2021cites this paper
• Evaluation of Neutrophil Dynamics Change by Protective Effect of Tadalafil After Renal Ischemia/Reperfusion Using In Vivo Real-time Imaging

  2021cites this paper
• Efficacy and safety of aildenafil citrate in Chinese men with erectile dysfunction: a multicenter, randomized, double-blind, placebo-controlled crossover trial

  2021cites this paper
• A validated LC-MS/MS assay for the quantification of phosphodiesterase-5 inhibitors in human plasma.

  2021cites this paper
• Phosphodiesterase-5 inhibitors ameliorate structural kidney damage in a rat model of contrast-induced nephropathy.

  2020cites this paper
• Real-World Assessment of the Impact of Erectile Dysfunction on Sexual Planning Behavior and Health- and Treatment-Related Outcomes Among Men in 8 Countries

  2020cites this paper
• Assessment Scales for Sexual Disorders—A Review

  2020cites this paper
• Role of Phosphodiesterase Inhibitors in Improving Urodynamic Parameters in Patients with Spinal Cord Injury: A Preliminary Report

  2020cites this paper
• Pharmacology of Male Sexual Function

  2020cites this paper
• Preparation of solid dispersions with respect to the dissolution rate of active substance

  2020cites this paper
• Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis

  2020cites this paper
• Determination of tadalafil in pharmaceutical samples by vertically oriented multi-walled carbon nanotube electrochemical sensing device

  2020cites this paper
• Tadalafil attenuates ischemic damage as well as reperfusion injury in the rat ovary

  2020cites this paper
• Unsafe Ingredients Included in Malaysian Food Drug Interphase (FDI) Products: Toyyiban perspective

  2020cites this paper
• Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part II on Urological Management).

  2020cites this paper
• Therapeutic Strategies for Erectile Dysfunction With Emphasis on Recent Approaches in Nanomedicine

  2020cites this paper
• The Use of Vasoactive Drugs in the Treatment of Male Erectile Dysfunction: Current Concepts

  2020cites this paper
• Meta-Analysis of the Long-Term Efficacy and Tolerance of Tadalafil Daily Compared With Tadalafil On-Demand in Treating Men With Erectile Dysfunction

  2019cites this paper
• Reflexionen über 50 Jahre Sexualmedizin in der Urologie mit Fokus auf männliche Sexualstörungen

  2019cites this paper
• Contemporary Vistas in Geriatric Sexuality

  2019cites this paper
• Eco-Friendly Tadalafil Surfactant-Free Dry Emulsion Tablets (SFDETs) Stabilized by In Situ Self-Assembled Aggregates of Natural Oil and Native Cyclodextrins

  2019cites this paper
• Comparison of the protective effects of sildenafil, vardenafil and tadalafil treatments in ischemia-reperfusion injury in rat ovary.

  2019cites this paper
• Erectile Dysfunction.

  2019cites this paper
• Acute pancreatitis induced by Tadalafil: a case report

  2019cites this paper
• Other (Bladder Cancer, Sexual Dysfunction)

  2018cites this paper
• Mental Health and Sexual Medicine: An Update

  2018cites this paper
• Erectile Dysfunction

  2018cites this paper
• Functional Nitric Oxide Nutrition to Combat Cardiovascular Disease

  2018cites this paper
• A systematic review and meta-analysis of clinical trials on saffron (Crocus sativus) effectiveness and safety on erectile dysfunction and semen parameters

  2018cites this paper
• Management of erectile dysfunction

  2018cites this paper
• A Systematic Overview of Reviews on the Efficacy of Complementary and Alternative Medicine in Erectile Dysfunction

  2018cites this paper
• Mesothelial Stem Cells and Stromal Vascular Fraction: Use in Functional Disorders, Wound Healing, Fat Transfer, and Other Conditions.

  2018cites this paper
• Tadalafil protector effect during ischemia-reperfusion in rats.

  2017cites this paper
• The Textbook of Clinical Sexual Medicine

  2017cites this paper
• Treating Sexual Problems in Aging Adults

  2017cites this paper
• Update on the Safety of Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction.

  2017cites this paper
• Sex and Pharmacological Sexual Enhancement

  2017cites this paper
• Formulation and evaluation of Tadalafil oral disintegrating tablets with enhanced dissolution rate by complexation

  2017cites this paper
• [Use of tadalafil in the rehabilitation of patients with a history of posterior urethral injury in the context of pelvic fracture].

  2017cites this paper
• Phosphodiesterase type 5 and cancers: progress and challenges

  2017cites this paper
• ERECTILE DYSFUNCTION AND ITS PHARMACOLOGY: AN OVERVIEW

  2017cites this paper
• An Overview of Nitrite and Nitrate: New Paradigm of Nitric Oxide

  2017cites this paper
• Standards for Clinical Trials in Male and Female Sexual Dysfunction: III. Unique Aspects of Clinical Trials in Male Sexual Dysfunction.

  2017cites this paper
• The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction

  2016cites this paper
• Standards for Clinical Trials in Male and Female Sexual Dysfunction: I. Phase I to Phase IV Clinical Trial Design.

  2016cites this paper
• Isolation and characterization of a tadalafil analogue, N-cyclopentyl nortadalafil in health supplement.

  2016cites this paper
• Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).

  2016cites this paper
• Avanafil - a further step to tailoring patient needs and expectations

  2016cites this paper
• Comparisons of regular and on-demand regimen of PED5-Is in the treatment of ED after nerve-sparing radical prostatectomy for Prostate Cancer

  2016cites this paper
• Evolution of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction in Taiwan

  2016cites this paper
• Tadalafil therapy for erectile dysfunction following prostatectomy

  2015cites this paper
• Amelioration of untreated restless legs syndrome by tadalafil in a patient with erectile dysfunction.

  2015cites this paper
• Formulation and Evaluation of Floatingtablet of Gliclazide using HPMC and Xanthan Gum

  2015cites this paper
• Pharmaceutical Prospective Process Validation Of Chloroquiune Tablets

  2015cites this paper
• Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil

  2015cites this paper
• Factores que influyen en la respuesta a los inhibidores de la fosfodiesterasa tipo cinco en monoterapia frente a tratamiento combinado en el tratamiento de la disfunción eréctil

  2015cites this paper
• Molecular mechanisms that underlie the sexual stimulant actions of Avicennia marina (Forssk.) Vierh. and Crocus sativus L.

  2015cites this paper
• Effect of the phosphodiesterase type 5 inhibitor tadalafil on pulmonary hemodynamics in a canine model of pulmonary hypertension.

  2014cites this paper
• Comparison of the efficacy and safety of 5-mg once-daily versus 5-mg alternate-day tadalafil in men with erectile dysfunction and lower urinary tract symptoms

  2014cites this paper
• Sildenafil Citrate for Prophylaxis of Nephropathy in an Animal Model of Contrast-Induced Acute Kidney Injury

  2014cites this paper
• An open-label, multicenter, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in Chinese men naïve to phosphodiesterase 5 inhibitor therapy

  2014cites this paper
• Psychosocial outcomes after initial treatment of erectile dysfunction with tadalafil once daily, tadalafil on demand or sildenafil citrate on demand: results from a randomized, open-label study

  2014cites this paper
• Evaluation of Tadalafil Nanosuspensions and Their PEG Solid Dispersion Matrices for Enhancing Its Dissolution Properties

  2014cites this paper
• PDE-5 inhibitors: clinical points.

  2014cites this paper
• Continuation and effectiveness of tadalafil once daily during a 6‐month observational study in erectile dysfunction: the EDATE study

  2014cites this paper
• Safety and efficacy of 20 mg pentadafil in Egyptian male patients with erectile dysfunction: a randomized, double-blinded, placebo-controlled, multicenter study

  2014cites this paper
• Uso recreativo dos inibidores da fosfodiesterase-5

  2014cites this paper
• Clinical and molecular genetics of the phosphodiesterases (PDEs).

  2014cites this paper
• Vardenafil dihydrochloride.

  2014cites this paper
• The Treatment for Erectile Dysfunction

  2013cites this paper
• An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors

  2013cites this paper
• PDE5 inhibitors: considerations for preference and long‐term adherence

  2013cites this paper
• A 6-month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Middle Eastern and North African men with erectile dysfunction

  2013cites this paper
• Pomegranate Extracts in the Management of Men's Urologic Health: Scientific Rationale and Preclinical and Clinical Data.

  2013cites this paper
• Tratamento da Disfunção Erétil após Prostatectomia Radical

  2013cites this paper
• Pomegranate Extracts in the Management of Men's Urologic Health: Scientific Rationale and Preclinical and Clinical Data

  2013cites this paper
• Managing erectile dysfunction in heart failure.

  2013cites this paper
• Molecular mechanisms that underlie the sexual stimulant actions of ginger (Zingiber officinale Rosocoe) and garden rocket (Eruca sativa L.)

  2013influential citation
• Korean Society for Sexual Medicine and Andrology (KSSMA) Guideline on Erectile Dysfunction

  2013cites this paper
• Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.

  2013cites this paper
• Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons

  2013cites this paper
• Chronic Low Dosing of Phosphodiesterase Type 5 Inhibitor for Erectile Dysfunction

  2012cites this paper
• Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitus.

  2012cites this paper